Adhera Therapeutics to Collaborate with Alberta Diabetes Institute, University of Alberta to Initiate Clinical Trial of MLR-1023 in Type 1 Diabetes

Stock Information for Adhera Therapeutics Inc

Loading

Please wait while we load your information from QuoteMedia.